📈 Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
Kingfa India Q3 FY26 Revenue Grows 11% YoY to ₹489.46 Cr; PAT at ₹45.17 Cr
Kingfa Science & Technology (India) reported a steady performance for Q3 FY 2025-26, with total revenue from operations growing 11.15% YoY to ₹489.46 crore. Net profit for the quarter stood at ₹45.17 crore, representing a sequential growth of 9.8% compared to Q2 FY26. The company's nine-month revenue also saw an 11.13% increase, reaching ₹1,417.08 crore. Domestic sales continue to dominate the revenue mix, accounting for 95% of the total quarterly turnover.
Key Highlights
Total Revenue from operations for Q3 FY26 increased 11.15% YoY to ₹48,945.96 Lakhs
Net Profit after tax rose to ₹4,517.44 Lakhs in Q3 FY26 from ₹4,114.38 Lakhs in Q2 FY26
Nine-month (9M) revenue grew by 11.13% YoY, reaching ₹1,41,708.30 Lakhs
Earnings Per Share (EPS) improved to ₹33.34 in Q3 FY26 compared to ₹30.36 in the previous quarter
Domestic sales contributed 95% of Q3 revenue (₹46,437.68 Lakhs), while exports accounted for 5%
💼 Action for Investors
The company demonstrates consistent growth and stable margins, making it a solid mid-cap pick in the specialty chemicals and plastics space. Investors should monitor the automotive sector's health as it remains a primary revenue driver for the company.
Kingfa Science & Technology Approves Q3 FY26 Unaudited Financial Results
Kingfa Science & Technology (India) Limited has approved its unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. The board meeting was held on February 7, 2026, and lasted over six hours, concluding at 4:10 P.M. While the specific financial figures were not detailed in the cover letter, the results have been reviewed by statutory auditors. This announcement fulfills the regulatory requirements under SEBI Regulations 30 and 33.
Key Highlights
Board approved unaudited financial results for the quarter and nine months ended December 31, 2025
The board meeting commenced at 10:00 A.M. and concluded at 4:10 P.M. on February 7, 2026
Statutory auditors have issued a Limited Review Report for the period
The approval covers both standalone and consolidated financial performance metrics
💼 Action for Investors
Investors should examine the detailed financial tables and profit margins once the full report is available to assess the company's growth trajectory. Monitor the stock for price sensitivity following the release of the specific revenue and PAT figures.
Kingfa Science & Technology Approves Q3 FY 2025-26 Financial Results
Kingfa Science & Technology (India) Limited has approved its unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. The board meeting, held on February 7, 2026, included a review of the Limited Review Report from the statutory auditors. This announcement marks the formal disclosure of the company's performance for the third quarter of the 2025-26 fiscal year. While the cover letter does not list specific profit figures, it confirms the completion of the regulatory review process.
Key Highlights
Board approved Unaudited Standalone and Consolidated Financial Results for Q3 and 9M FY 2025-26.
Limited Review Report issued by Statutory Auditors was reviewed and taken on record.
The board meeting was comprehensive, lasting over 6 hours from 10:00 A.M. to 4:10 P.M.
Compliance maintained with SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations.
💼 Action for Investors
Investors should analyze the detailed financial tables attached to the filing to evaluate revenue growth and margin trends. Compare these results against industry peers in the polymer and plastic compounds sector.
Kingfa Science & Technology Approves Q3 FY 2025-26 Unaudited Financial Results
Kingfa Science & Technology (India) Limited has officially approved its unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. The board meeting, held on February 7, 2026, concluded with the adoption of the financial statements and the accompanying Limited Review Report from statutory auditors. This filing confirms the completion of the mandatory Q3 reporting cycle for the company. Investors should now focus on the specific revenue and margin data within the full financial statements to gauge operational efficiency.
Key Highlights
Board approved Unaudited Standalone and Consolidated Financial Results for the quarter ended Dec 31, 2025.
The board meeting was conducted on February 7, 2026, spanning from 10:00 A.M. to 4:10 P.M.
Statutory Auditors issued a Limited Review Report for both the quarter and nine-month periods.
The announcement complies with Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
💼 Action for Investors
Investors should review the detailed profit and loss tables in the full report to analyze year-on-year growth and margin trends. Compare these results against industry peers in the polymer and plastic compounds sector to assess market positioning.